Results 1 to 10 of about 430,270 (245)
J Infect Dis, 2021 Abstract Hepatitis B is caused by the hepatitis B virus (HBV), which infects the liver and may lead to chronic liver disease, including cirrhosis and hepatocellular carcinoma. HBV represents a worldwide public health problem, causing major morbidity and mortality.
Pattyn J +3 more
europepmc +6 more sources
Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000. [PDF]
Stud Hist Philos Biol Biomed Sci, 2017 The approval, from 1986, of a series of recombinant hepatitis B vaccines was a landmark both in the growth of biotechnology and in the development of the vaccine innovation system.
Huzair F, Sturdy S.
europepmc +2 more sources
Journal of Hepatology, 2003 Yeast-derived hepatitis B vaccines, containing the small HBV envelope protein SHBAg, are immunogenic, safe and cost-effective in prevention of hepatitis B virus infection in neonates, children and adults. Newly developed pre-S/S hepatitis B vaccines may play a role in inducing fast and augmented seroconversion rates in special risk groups.
D. Shouval
openaire +3 more sources
Vaccination Strategies Against Hepatic Diseases: A Scoping Review. [PDF]
Vaccines (Basel)Background/Objectives: Viral hepatitis remains a significant global cause of chronic liver disease, highlighting the importance of effective vaccination strategies. This review assesses recent evidence on vaccine safety and effectiveness.
Beyzaei Z +3 more
europepmc +2 more sources
Booster Vaccination Against Invasive Pneumococcal Disease and Hepatitis B in Previously Vaccinated Solid Organ Transplant Recipients Without Seroprotection. [PDF]
Vaccines (Basel)Background: Despite pre-transplantation vaccination against invasive pneumococcal disease (IPD) and hepatitis B virus (HBV), most solid organ transplant (SOT) recipients are without post-transplantation seroprotection against IPD and HBV.
Sejerøe-Olsen J +9 more
europepmc +2 more sources
Hepatitis B Vaccine: Four Decades on
VaccinesHepatitis B virus is a substantial contributor to cirrhosis and hepatocellular carcinoma (HCC) globally. Vaccination is the most effective method for prevention of hepatitis B and its associated morbidity and mortality, and the only method to prevent ...
Maria Mironova, Marc G. Ghany
doaj +2 more sources
HBV Vaccines: Advances and Development
Vaccines, 2023 Hepatitis B virus (HBV) infection is a global public health problem that is closely related to liver cirrhosis and hepatocellular carcinoma (HCC). The prevalence of acute and chronic HBV infection, liver cirrhosis, and HCC has significantly decreased as ...
Faisal Mahmood +9 more
doaj +1 more source
Asian Journal of Medical Sciences, 2023 Background: Hepatitis B virus (HBV) infection affects more than 2 billion individuals globally HBV. The chance of dying from liver cirrhosis, acute fulminant liver disease, or hepatocellular carcinoma (HCC) is present in 240 million of these chronic HBV ...
Ramesh Thanikachalam +2 more
doaj +1 more source
Pediatric Discovery, 2023 Our aim is an achievement of a 100 percent vaccination rate without toxic vaccine effects. We did a comprehensive literature review on aluminum neurotoxicity and early neonatal hepatitis B vaccination.
Aleksandar Cirovic +3 more
doaj +1 more source
EVALUATION OF VACCINATION RESPONSE IN CHILDREN AFTER TREATMENT FOR ACUTE LEUKEMIA
Hematology, Transfusion and Cell Therapy, 2021 Objective: Our study aims to evaluate the patients’ immunity regarding childhood vaccination after leukemia treatment and determine the vaccines that require additional doses. Methodology: Sixty-six patients who were followed up with the diagnosis of ALL
Elif KILIC KONTE +4 more
doaj +1 more source